PIK3CA C-terminal frameshift mutations are novel oncogenic events that sensitize tumors to PI3K-α inhibition. - Spangle JM; Von T; Pavlick DC; Khotimsky A; Zhao JJ; Roberts TM (Proceedings of the National Academy of Sciences of the United States of America, 2020)